Non classé

DiCE Helps Shape Global Conversations on Access to Medicines at Making Access Happen 2026

DiCE helped drive global conversations on access to medicines, biosimilars, patient advocacy, and digital innovation at Making Access Happen 2026, ...

Read

Building Europe’s Trusted Cancer Information Portal: DiCE Helps Put Patients at the Centre of EU-CIP

DiCE joined EU-CIP partners in Budapest to help shape a future European cancer information portal, ensuring patients, carers, and families can acce...

Read

Structured Exercise Helps Colon Cancer Patients Live Longer While Lowering Healthcare Costs

The American Society of Clinical Oncology (ASCO) Annual Meeting continues to be one of the most important events for cancer research, bringing toge...

Read

A Shared Vision for Patient-Centred Oncology: Professor Florian Lordick Candidate for ESMO President

Professor Florian Lordick is standing for President of the European Society for Medical Oncology with a vision centred on equity, innovation, and m...

Read

From Blood Tests to Better Decisions: GUIDE.MRD Advances the Future of Personalised Cancer Care

GUIDE.MRD partners gathered in Switzerland to advance liquid biopsy research in colorectal, pancreatic, and lung cancers. The project aims to detec...

Read

Biosimilars, Access, and the Future of Patient Care in Europe

Biosimilars are reshaping conversations around patient access, healthcare sustainability, and resilience across Europe. At the 2026 Biosimilar Medi...

Read

TOGAS Closes in Riga: Shaping the Future of Gastric Cancer Prevention in Europe

At the TOGAS Closing Meeting in Riga, partners from across Europe shared key findings on gastric cancer prevention and screening. DiCE highlighted ...

Read

Rising Early-Onset Cancer: Rethinking Care for Younger Adults

Experts at TSJCI highlighted the growing burden of early-onset cancers, calling for tailored screening, multidisciplinary research, and age-appropr...

Read

Switching Off KRAS: A Promising Breakthrough in Pancreatic Cancer Treatment

Results from the RASolute 302 phase 3 trial show the targeted drug Daraxonrasib improves survival in metastatic pancreatic cancer after prior treat...

Read

Landmark New England Journal of Medicine (NEJM) Publication Advances Gastric Cancer Prevention

A new New England Journal of Medicine paper, led by International Agency for Research on Cancer, outlines practical guidance for Helicobacter pylor...

Read

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.